Share on StockTwits
 

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 17,200 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were purchased at an average price of $9.00 per share, with a total value of $154,800.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,887,500. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Opko Health (NYSE:OPK) traded up 1.02% during mid-day trading on Monday, hitting $8.92. 1,103,065 shares of the company’s stock traded hands. Opko Health has a 52-week low of $6.14 and a 52-week high of $12.95. The stock’s 50-day moving average is $8.34 and its 200-day moving average is $9.17. The company’s market cap is $3.639 billion.

OPK has been the subject of a number of recent research reports. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note on Friday, December 20th. Analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note on Wednesday, December 18th.

OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.